BRAF V600E analysis for the differentiation of papillary craniopharyngiomas and Rathke's cleft cysts

Neuropathology and Applied Neurobiology

Volumn 41, Issue 6, 2015, Pages 733-742

  Schweizer, Leonille ^a,b   Capper, David ^a,b   Hölsken, Annett ^c   Fahlbusch, Rudolf ^d   Flitsch, Jörg ^e   Buchfelder, Michael ^c   Herold Mende, Christel ^a   von Deimling, Andreas ^a,b   Buslei, Rolf ^c  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^c UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^d INTERNATIONAL NEUROSCIENCE INSTITUTE   (Germany)

^e UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

BRAF V600E mutation; Papillary craniopharyngioma; Pyrosequencing; Rathke's cleft cysts; VE1 immunohistochemistry

Indexed keywords

B RAF KINASE; EPITOPE; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY VE1; PHENYLALANINE; UNCLASSIFIED DRUG; VALINE; BRAF PROTEIN, HUMAN;

ADULT; AGED; AMINO ACID SUBSTITUTION; ARTICLE; CANCER PATIENT; CANCER SURGERY; CLINICAL EVALUATION; CONTROLLED STUDY; CRANIOPHARYNGIOMA; FEMALE; GENE FREQUENCY; GENE MUTATION; GENETIC ANALYSIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PRIORITY JOURNAL; PYROSEQUENCING; RATHKE CLEFT CYST; REOPERATION; SELLA TURCICA; SQUAMOUS CELL METAPLASIA; TISSUE SECTION; TUMOR DIFFERENTIATION; TUMOR LOCALIZATION; TUMOR VOLUME; YOUNG ADULT; BRAIN CYST; DIFFERENTIAL DIAGNOSIS; GENETICS; IMMUNOLOGY; MUTATION; PATHOLOGY;

ADULT; AGED; ANTIBODIES, MONOCLONAL; CENTRAL NERVOUS SYSTEM CYSTS; CRANIOPHARYNGIOMA; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; MALE; MIDDLE AGED; MUTATION; PROTO-ONCOGENE PROTEINS B-RAF; YOUNG ADULT;

EID: 84942079456     PISSN: 03051846     EISSN: 13652990     Source Type: Journal    
DOI: 10.1111/nan.12201     Document Type: Article

References (20)

1. Hofmann BM, Kreutzer J, Saeger W, Buchfelder M, Blumcke I, Fahlbusch R, Buslei R. Nuclear beta-catenin accumulation as reliable marker for the differentiation between cystic craniopharyngiomas and Rathke cleft cysts: a clinico-pathologic approach. Am J Surg Pathol 2006; 30: 1595-1603
2. Ogawa Y, Watanabe M, Tominaga T. Rathke's cleft cysts with significant squamous metaplasia-high risk of postoperative deterioration and close origins to craniopharyngioma. Acta Neurochir (Wien) 2013; 155: 1069-1075
3. Zada G, Lin N, Ojerholm E, Ramkissoon S, Laws ER. Craniopharyngioma and other cystic epithelial lesions of the sellar region: a review of clinical, imaging, and histopathological relationships. Neurosurg Focus 2010; 28: E4
4. Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A, Scheithauer BW, Kleihues P. The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 2007; 114: 97-109
5. Okada T, Fujitsu K, Miyahara K, Ichikawa T, Takemoto Y, Niino H, Yagishita S, Shiina T. Ciliated craniopharyngioma - case report and pathological study. Acta Neurochir (Wien) 2010; 152: 303-306, discussion 7
6. Matsushima T, Fukui M, Ohta M, Yamakawa Y, Takaki T, Okano H. Ciliated and goblet cells in craniopharyngioma. Light and electron microscopic studies at surgery and autopsy. Acta Neuropathol 1980; 50: 199-205
7. Kim JE, Kim JH, Kim OL, Paek SH, Kim DG, Chi JG, Jung HW. Surgical treatment of symptomatic Rathke cleft cysts: clinical features and results with special attention to recurrence. J Neurosurg 2004; 100: 33-40
8. Wolfe SQ, Heros RC. A Rathke cleft cyst to craniopharyngioma: is there a spectrum? J Neurosurg 2010; 112: 1322-1323, discussion 3
9. Buslei R, Nolde M, Hofmann B, Meissner S, Eyupoglu IY, Siebzehnrubl F, Hahnen E, Kreutzer J, Fahlbusch R. Common mutations of beta-catenin in adamantinomatous craniopharyngiomas but not in other tumours originating from the sellar region. Acta Neuropathol 2005; 109: 589-597
10. Brastianos PK, Taylor-Weiner A, Manley PE, Jones RT, Dias-Santagata D, Thorner AR, Lawrence MS, Rodriguez FJ, Bernardo LA, Schubert L, Sunkavalli A, Shillingford N, Calicchio ML, Lidov HG, Taha H, Martinez-Lage M, Santi M, Storm PB, Lee JY, Palmer JN, Adappa ND, Scott RM, Dunn IF, Laws ER Jr, Stewart C, Ligon KL, Hoang MP, Van Hummelen P, Hahn WC, Louis DN, Resnick AC, Kieran MW, Getz G, Santagata S. Exome sequencing identifies BRAF mutations in papillary craniopharyngiomas. Nat Genet 2014; 46: 161-165
11. Larkin SJ, Preda V, Karavitaki N, Grossman A, Ansorge O. BRAF V600E mutations are characteristic for papillary craniopharyngioma and may coexist with CTNNB1-mutated adamantinomatous craniopharyngioma. Acta Neuropathol 2014; 127: 927-929
12. Capper D, Preusser M, Habel A, Sahm F, Ackermann U, Schindler G, Pusch S, Mechtersheimer G, Zentgraf H, von Deimling A. Assessment of BRAF V600E mutation status by immunohistochemistry with a mutation-specific monoclonal antibody. Acta Neuropathol 2011; 122: 11-19
13. Sperveslage J, Gierke M, Capper D, Honegger J, Sipos B, Beschorner R, Schittenhelm J. VE1 immunohistochemistry in pituitary adenomas is not associated with BRAF V600E mutation. Acta Neuropathol 2013; 125: 911-912
14. Bosmuller H, Fischer A, Pham DL, Fehm T, Capper D, von Deimling A, Bonzheim I, Staebler A, Fend F. Detection of the BRAF V600E mutation in serous ovarian tumors: a comparative analysis of immunohistochemistry with a mutation-specific monoclonal antibody and allele-specific PCR. Hum Pathol 2013; 44: 329-335
15. Tsiatis AC, Norris-Kirby A, Rich RG, Hafez MJ, Gocke CD, Eshleman JR, Murphy KM. Comparison of Sanger sequencing, pyrosequencing, and melting curve analysis for the detection of KRAS mutations: diagnostic and clinical implications. J Mol Diagn 2010; 12: 425-432
16. Arcila M, Lau C, Nafa K, Ladanyi M. Detection of KRAS and BRAF mutations in colorectal carcinoma roles for high-sensitivity locked nucleic acid-PCR sequencing and broad-spectrum mass spectrometry genotyping. J Mol Diagn 2011; 13: 64-73
17. Koelsche C, Wohrer A, Jeibmann A, Schittenhelm J, Schindler G, Preusser M, Lasitschka F, von Deimling A, Capper D. Mutant BRAF V600E protein in ganglioglioma is predominantly expressed by neuronal tumor cells. Acta Neuropathol 2013; 125: 891-900
18. Ogawa Y, Watanabe M, Tominaga T. Prognostic factors of operated Rathke's cleft cysts with special reference to re-accumulation and recommended surgical strategy. Acta Neurochir (Wien) 2011; 153: 2427-2433, discussion 33
19. Aho CJ, Liu C, Zelman V, Couldwell WT, Weiss MH. Surgical outcomes in 118 patients with Rathke cleft cysts. J Neurosurg 2005; 102: 189-193
20. Rahman MA, Salajegheh A, Smith RA, Lam AK. BRAF inhibitors: from the laboratory to clinical trials. Crit Rev Oncol Hematol 2014; 90: 220-232